Select for export Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2024.0032 PubMed 40337756 Copy citation Copy BibTeX Psychedelic Medicine 2024-11-17 Shakila Meshkat, Erica Kaczmarek, Zoe Doyle, Ryan M. Brudner, Fabiano A. Gomes, Marc G. Blainey OpenAlex Published psilocybin DepressionChronic PainTreatment-Resistant Depression Other More
Select for export PAPR: Psilocybin-assisted Psychotherapy + Mindfulness-Based Stress Reduction (MBSR) for Front-line Healthcare Provider COVID-19 Related Burnout Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-11-11 University of Utah ClinicalTrials.gov CLINICAL TRIAL psilocybin Depression Clinical Trial More
Select for export Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT2A receptor activation and psychedelic-like activity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.ejmech.2024.117049 PubMed 39541872 Copy citation Copy BibTeX Unknown journal 2024-11-11 Zhang M, Yang Y, Yang Z, Wen X, Zhang C, Xiao P Europe PMC Published psilocybinpsilocin DepressionReceptor PharmacologyDrug Interactions Other More
Select for export Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuits Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.11.06.622302 Copy citation Copy BibTeX bioRxiv 2024-11-06 Pasquini L, Vohryzek J, Escrichs A, Sanz Perl Y, Ponce-Alvarez A, Idesis S bioRxiv PREPRINT (not peer reviewed) psilocybin DepressionEating DisordersBrain Imaging Other More
Select for export Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2024.1485337 PubMed 39568756 Copy citation Copy BibTeX Frontiers in Psychiatry 2024-11-05 Cristiano Chaves, Rafael G. dos Santos, Serdar Dursun, Massimo Tusconi, Mauro Giovanni Carta, Elisa Brietzke OpenAlex Published psilocybin DepressionAnxietyPTSD Review Article More
Select for export Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/j8zb5 Copy citation Copy BibTeX PsyArXiv 2024-11-03 Aday JS, McAfee J, Conroy DA, Hosanagar A, Tarnal V, Weston C PsyArXiv PREPRINT (not peer reviewed) psilocybin AnxietyChronic PainHeadache / Migraine Randomized Controlled Trial More
Select for export Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trial Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2024-11-03 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin AnxietyChronic PainHeadache / Migraine Randomized Controlled Trial More
Select for export Pyramidal cell types and 5-HT2A receptors are essential for psilocybin’s lasting drug action Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.11.02.621692 Copy citation Copy BibTeX bioRxiv 2024-11-02 Shao L, Liao C, Davoudian PA, Savalia NK, Jiang Q, Wojtasiewicz C bioRxiv PREPRINT (not peer reviewed) psilocybin NeuroplasticityBrain ImagingReceptor Pharmacology Animal Study More
Select for export A Registered Clinical Trial of PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-10-29 Filament Health Corp. ClinicalTrials.gov CLINICAL TRIAL psilocybin Clinical TrialSafety Clinical Trial More
Select for export Psilocybin Reduces Grooming in the SAPAP3 Knockout Mouse Model of Compulsive Behaviour Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.10.23.619763 Copy citation Copy BibTeX bioRxiv 2024-10-23 Gattuso JJ, Wilson C, Hannan AJ, Renoir T. bioRxiv PREPRINT (not peer reviewed) psilocybin AnxietyReceptor PharmacologyAnimal Study Animal Study More
Select for export Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-10-17 University Health Network, Toronto ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionBrain ImagingMechanism of Action Randomized Controlled Trial More
Select for export Expanding the Therapeutic Horizons of Psilocybin in Mental Health. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsmedchemlett.4c00488 PubMed 39563826 Copy citation Copy BibTeX Unknown journal 2024-10-14 Kargbo RB. Europe PMC Published psilocybin DepressionAnxietyWellbeing Clinical Trial More
Select for export Human brain changes after first psilocybin use Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.10.11.617955 Copy citation Copy BibTeX bioRxiv 2024-10-13 Lyons T, Spriggs M, Kerkelä L, Rosas F, Roseman L, Mediano P bioRxiv PREPRINT (not peer reviewed) psilocybin Brain ImagingAgingWellbeing Other More
Select for export The therapeutic potential and mechanisms of action of psilocybin-assisted therapy in anorexia nervosa treatment Abstract available at the source but not redistributed here. Read at source. Details DOI 10.25560/118978 Copy citation Copy BibTeX Open MIND 2024-10-09 Hannah Douglass OpenAlex Published psilocybin DepressionAnxietyEating Disorders Observational Study More
Select for export Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/head.14846 PubMed 39382331 Copy citation Copy BibTeX Headache The Journal of Head and Face Pain 2024-10-08 James Rucker, Matthew Butler, Sadie Hambleton, Catherine Bird, Mathieu Seynaeve, Sanjay Cheema OpenAlex Published psilocybin Chronic PainHeadache / MigrainePharmacology Clinical Trial More
Select for export A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 (psilocybin) in Healthy Participants Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-10-08 MycoMedica Life Sciences PBC ClinicalTrials.gov CLINICAL TRIAL psilocybin PharmacologyMicrodosingClinical Trial Clinical Trial More
Select for export Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpt.3459 PubMed 39345195 Copy citation Copy BibTeX Unknown journal 2024-09-29 Halman A, Conyers R, Moore C, Khatri D, Sarris J, Perkins D. Europe PMC Published psilocybin PharmacologyReview ArticleAnimal Study Review Article More
Select for export Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study No abstract availability was recorded for this entry. Details DOI 10.1016/j.jad.2024.09.133 PubMed 39343309 Copy citation Copy BibTeX Journal of Affective Disorders 2024-09-26 Sara Ellis, Catherine Bostian, Wendy Feng, E. Grace Fischer, Garrett Schwartz, Katherine Eisen OpenAlex Published psilocybin DepressionChronic PainClinical Trial Clinical Trial More
Select for export Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.61373/pp024r.0028 PubMed 40458078 Copy citation Copy BibTeX Psychedelics. 2024-09-23 Xi Zhu, Chen Zhang, David J. Hellerstein, Jamie D. Feusner, Michael G. Wheaton, Gloria J. Gomez OpenAlex Published psilocybin DepressionBrain ImagingReceptor Pharmacology Other More
Select for export Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates the gabapentin-mediated analgesia Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-5026806/v1 Copy citation Copy BibTeX Research Square 2024-09-19 Askey T, Allen-Ross D, Lasrado R, Gilmour G, Hunt S, Tamagnini F Europe PMC PREPRINT (not peer reviewed) psilocybin Chronic PainAnimal Study Animal Study More
